We describe the synthesis of 2-[(4-hydroxyphenyl)thio]-7-isopropoxy-5,6-dimethoxy-4H-chromen-4-one 2 from 3,4,5-trimethoxyphenol 6 via the key intermediate, 3-iodo-7-isopropoxy-5,6-dimethoxy-4H-chromen-4-one 3. An important feature of this synthetic scheme involves selective alkylation, which can be achieved by two different routes. One route involves the selective isopropylation of a triacetate derivative 4 under basic conditions. The second route employs the selective demethylation of a trimethoxy derivative 5 under acidic conditions followed by isopropylation. The product of these alternative routes, compound 3, is then converted to a capillarisin sulfur analogue 2 in a one-pot reaction via the imidazolyl intermediate 22.
Capillarisin 1, 1) a bioactive constituent of Artemisiae Capillaris Herba, is an antioxidant, 2) as well as a choleretic 3) and antitumor agent 4) and an inhibitor of aldose reductase (AR).
5)
We have synthesized a number of capillarisin analogues and tested their ability to inhibit AR. 6) Among them, the sulfur analogue 2, which was prepared from capillarisin 1 by a semi-synthetic method (Chart 1), showed excellent in vitro activity with an IC 50 of 3ϫ10 Ϫ8 mol/l against rat lens AR. Therefore compound 2 is an excellent lead structure for an AR inhibitor. 6-Demethoxycapillarisin has been synthesized by two groups, 7, 8) but total synthesis of 1 has not been reported. During the development of a drug to treat diabetic complications, we devised a synthetic route to the sulfur analogue 2 from a commercially available compound.
A key feature of this synthesis is the selective construction of the A-ring substituted with trialkoxy groups and introduction of the phenylthio group into the 2-position in its structure. The retrosynthetic analysis of 2 is outlined in Fig. 1 . A substitution reaction using 3-iodochromone 3 with 4-hydroxybenzenethiol affords 2. To selectively arrange the 7-isopropoxy-5,6-dimethoxy groups on the A-ring of 3, two synthetic routes were investigated. The first route involves the selective isopropylation using a triacetate derivative 4 (route a), and the second route involves selective demethylation of the trimethoxy derivative 5 (route b). Compounds 4 and 5 can be prepared from 3,4,5-trimethoxyphenol 6. In this paper, we describe the total synthesis of the novel capillarisin derivative 2 by these two methods.
Synthesis of 3 via 4 (Route a) The starting material 7, is commercially available or can easily be prepared from 3,4,5-trimethoxyphenol 6.
9) Condensation of 7 with N,N-dimethylformamide dimethyl acetal gave 8 in 91% yield. Cyclyzation 10) of 8 using iodine afforded 3-iodochromone 9 in 84% yield (Chart 2).
To obtain the desired compounds, 14 or 15, demethylation of compound 9 was carried out under various conditions (Table 1) . Demethylation proceeded in the order of the position 5, 6 and 7 using Lewis acids (runs 1-4). Interestingly, the reaction of 9 with sulfuric acid (run 5) occurred selec- tively at the 6-position to afford 13 in 96% yield. Additionally, compound 10 was exclusively obtained after treatment with lithium iodide (run 6). However, the desired compounds, 14 and 15, could not be obtained by this method. We then tried selective isopropylation at the 7-position using the trihydroxy derivative 12 under various conditions (base; K 2 CO 3 , Cs 2 CO 3 or Li 2 CO 3 : solvent; DMF, MEK, acetone or EtOH). However, the yield (maximum 43%) of desired compound 16 was unsatisfactory (Chart 3). Presumably the reactivity of the 7-hydroxy group was equal to that of the 6-hydroxy group, and the substrate 12 is unstable under basic conditions.
Synthesis of a Capillarisin
We judged that direct isopropylation of 12 is difficult, and therefore adopted a selective alkylation methodology using methyl gallate. 11) Compound 12 was converted to the triacetate 4 in 83% yield, and then reacted with 2-iodopropane in the presence of potassium carbonate. As expected, the 7-acetoxy group para to the carbonyl group reacted selectively to give the desired compound 17 in 86% yield. Hydrolysis of 17 followed by methylation afforded the key intermediate 3 in 86% yield (Chart 4).
Synthesis of 3 via 5 (Route b)
Since selective demethylation of 9 failed (Table 1) , conversion of 9 to 3 was achieved in 5 steps (route a). Thus we planned an alternative route involving the selective demethylation at the 7-position via intermediate 5, possessing a carbonyl function at the 8-position.
Friedel-Crafts reaction of 3,4,5-trimethoxyphenol 6 using acetic anhydride and aluminum chloride in nitromethane afforded the diacetyl derivative 18 in 74% yield. Condensation of 18 with N,N-dimethylformamide dimethyl acetal (1 eq) followed by treatment with iodine gave 5. Demethylation of 5 using titanium tetrachloride as Lewis acid proceeded selectively to afford the 5,7-dihydroxy-6-methoxy derivative 20 as expected. The acetyl group of 20 was then removed by reaction with trifluoromethanesulfonic acid 12) to afford 14 in 89% yield. Isopropylation at the 7-position followed by methylation at the 5-position of 14 gave compound 3 in 62% yield (Chart 5).
Preparation of 2 from 3 The conversion of 3 to 2 is outlined in Chart 6. A direct substitution reaction of the 3-iododerivative 3 with 4-hydroxybenzenethiol gave only the reduced product 21 in 88% yield. It was reported that 3-iodochromone reacted with imidazole to give 2-(1-imidazolyl)chromone. 13) Treatment of 3 with imidazole in the presence of potassium carbonate in DMF gave the imidazolyl derivative 22, which without isolation then underwent a substitution reaction with 4-hydroxybenzenethiol to give 2 in 86% yield. These two steps could proceed either in a one-pot reaction or step-by-step.
Conclusion
We have developed two synthetic routes for the preparation of the key intermediate 3 in the synthesis of a capillarisin-analogue 2. Both reaction schemes use readily available starting reagents. One route employs the selective isopropylation of 4, whereas the second route involves the selective demethylation of 5. Compound 2 was prepared from 3 in a one-pot reaction via the imidazoyl derivative 22.
Experimental
Melting points were measured by the use of a Yanaco micro melting point apparatus and are uncorrected. 
5,6,7-Trihydroxy-3-iodo-4H-chromen-4-one (12)
To a suspension of 9 (497.9 mg, 1.38 mmol) in toluene (10 ml) was added AlCl 3 (915 mg, 6.88 mmol) at room temperature. The mixture was then heated and stirred at 100°C for 6 h. After cooling, the reaction mixture was poured into 3 N-HCl, and stirred at room temperature for 1 h. The reaction mixture was extracted with EtOAc, dried over Na 2 SO 4 
5,6-Diacetoxy-3-iodo-7-isopropoxy-4H-chromen-4-one (17)
A mixture of 4 (928 mg, 2.08 mmol), 2-iodopropane (0.416 ml, 4.16 mmol), and K 2 CO 3 (861 mg, 6.24 mmol) in DMF (4.6 ml) was stirred at 40°C for 6 h. H 2 O was added to the mixture, and the mixture was extracted with EtOAc, dried over Na 2 SO 4 and concentrated. The residue was purified by flash chromatography on silica gel (hexane/EtOAcϭ2/1) to give the title compound (795.5 mg, 86% 3-Iodo-7-isopropoxy-5,6-dimethoxy-4H-chromen-4-one (3) 1) To a solution of 17 (793.8 mg, 1.78 mmol) in acetone (8 ml) was added 6 N-HCl, and the mixture was stirred at 70°C for 5 h. After adding H 2 O the mixture was extracted with EtOAc, dried over Na 2 SO 4 and concentrated to give 5,6-hydroxy-3-iodo-7-isopropoxy-4H-chromen-4-one (554 mg, 86%). Recrystallization from EtOAc-hexane afforded colorless crystals: mp 151-152°C. 2) A mixture of the above compound (554 mg, 1.53 mmol), K 2 CO 3 (1.47 g, 10.68 mmol) and iodomethane (0.665 ml, 10.68 mmol) in DMF (8 ml) was stirred at 40°C for 5 h. After adding H 2 O the mixture was extracted with EtOAc, dried over Na 2 SO 4 and concentrated. The residue was purified by flash chromatography on silica gel (hexane/EtOAcϭ4/1) to give the title compound (597.8 mg, 100%). Recrystallization from EtOAc-hexane afforded colorless crystals: mp 99-100°C. 8-Acetyl-5,7-dihydroxy-3-iodo-6-methoxy-4H-chromen-4-one (20) To a solution of 5 (100 mg, 0.248 mmol) in toluene (2 ml) was added TiCl 4 (0.74 ml, 1 M solution in toluene) at room temperature, and the mixture was then stirred at 100°C for 1 h. After cooling, the reaction mixture was poured into 3 N-HCl and stirred at 80°C for 0.5 h. The reaction mixture was extracted with EtOAc, dried over Na 2 SO 4 and concentrated. The residue was purified by flash chromatography on silica gel (CH 2 Cl 2 /EtOAcϭ30/1) to give the title compound (68 mg, 73%). Recrystallization from EtOAc afforded colorless crystals: mp 224-226°C. 2-[(4-Hydroxyphenyl)thio]-7-isopropoxy-5,6-dimethoxy-4H-chromen-4-one (2) A mixture of 3 (225.2 mg, 0.578 mmol), imidazole (79 mg, 1.16 mmol) and K 2 CO 3 (798 mg, 5.78 mmol) in DMF (2.3 ml) was stirred at 80°C for 2 h. After cooling, a solution of 4-hydroxybenzenethiol (146 mg, 1.16 mmol) in acetone (1 ml) was added to the reaction mix, and the mixture was stirred at room temperature for 2 h. The reaction mixture was poured into 3 N-HCl, extracted with CH 2 Cl 2 , dried over Na 2 SO 4 and concentrated. The residue was purified by flash chromatography on silica gel (CH 2 Cl 2 /acetoneϭ10/1) to give the title compound (193 mg, 86%). Recrystallization from EtOH afforded colorless crystals: mp 213-215°C. 
